引用次数
引用: 40,448
H-指数: 103
I10-指数 : 362
出版物: 597
Flk-1 as a Target for Tumor Growth Inhibition
Orfi L , Levitzki A , Strawn Lm , Keri G
Cancer Research 56 ( 15) 3540 -3545
444
1996
Altered efficacy and selectivity of tyrosine kinase inhibitors of the activated states of protein tyrosine kinases.
Levitzki A , Böhmer Fd
Anti-cancer Drug Design 13 ( 6) 731 -734
9
1998
Resolution, reconstitution, and mode of action of the beta-adrenergic receptor-dependent adenylate cyclase.
Levitzki A , Arad H , Helmreich Ej , Feder D
Advances in cyclic nucleotide and protein phosphorylation research 17 61 -71
1984
The coupling of receptors to adenylate cyclases [proceedings].
Levitzki A
Psychopharmacology Bulletin 16 ( 4) 17
1980
SRC as a target for anti-cancer drugs.
Levitzki A
Anti-cancer Drug Design 11 ( 3) 175 -182
33
1996
Theories and predictions of models describing sequential interactions between the receptor, the GTP regulatory unit, and the catalytic unit of hormone dependent adenylate cyclases.
Tolkovsky Am , Levitzki A
Journal of cyclic nucleotide research 7 ( 3) 139
14
1981
Outward pressure within erythrocytes.
Levitzki A , Porath-Füredi A
Israel journal of medical sciences 17 ( 1) 36 -40
1981
The hormonal regulation of adenylate cyclase.
Levitzki A , Im Mj , Feder D , Helmreich Ej
Biochemical Society symposium 52 145 -151
2
1986
Mechanism of control of the turkey erythrocyte beta-adrenoceptor dependent adenylate cyclase by guanyl nucleotides: a minimum model.
Levitzki A , Tolkovsky Am , Braun S
Journal of cyclic nucleotide research 8 ( 3) 133
5
1982
Activation of adenylate cyclase from purified platelet membranes by prostaglandin E1 and its inhibition by L-epinephrine: mechanistic effects.
Levitzki A , Steer Ml , Braun S , Lester Ha
Journal of cyclic nucleotide research 8 ( 5) 309
5
1982
Inhibitory GTP binding protein G/sub i/ regulates US -adrenoceptor affinity towards US -agonists
A. Levitzki , I. Marbach
Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
1987
Targeting signal transduction for disease therapy
A. Levitzki
Cellular & Molecular Biology Letters 03 ( 3)
1998
Inhibition of Platelet-Derived Growth Factor and Epidermal Growth Factor Receptor Signaling Events after Treatment of Cells with Specific Synthetic Inhibitors of Tyrosine Kinase Phosphorylation
A. Levitzki , G. Mcmahon , A. Gazit , L. J. Huber
Journal of Pharmacology and Experimental Therapeutics 285 ( 2) 844 -852
41
1998
Tyrphostins That Suppress the Growth of Human Papilloma Virus 16-Immortalized Human Keratinocytes
A. Levitzki , Z. Hartzstark , R. Levitzki , S. Rosenbaum-Mitrani
Journal of Pharmacology and Experimental Therapeutics 290 ( 3) 1442 -1457
26
1999
High-performance liquid chromatographic analysis of the tyrphostin AG1478, a specific inhibitor of the epidermal growth factor receptor tyrosine kinase, in mouse plasma
A. Levitzki , A. W. Burgess , A. G. Ellis , L. K. Webster
Journal of Chromatography B 754 ( 1) 193 -19915
1
2001
Amifostine pretreatment allows the use of higher doses' of the bcr-abl-specific tyrosine kinase innibitor agh12
E. Regazzi , G. Sammarelli , V. Rizzoli , C. Almici
Experimental Hematology 25 ( 8)
1997
Analytical determination of receptor-ligand dissociation constants of two populations of receptors from displacement curves
H. Almagor , A. Levitzki
Proceedings of the National Academy of Sciences of the United States of America 87 ( 17) 6482 -6486
6
1990
Stochastic algorithm for kinase homology model construction.
A. Rayan , E. Noy , D. Chema , A. Levitzki
Current Medicinal Chemistry 11 ( 6) 675 -692
18
2004
On a fundamental structure of gene networks in living cells.
N. Kravchenko-Balasha , A. Levitzki , A. Goldstein , V. Rotter
Proceedings of the National Academy of Sciences of the United States of America 109 ( 12) 4702 -4707
41
2012
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase.
A.G. Ellis , M.M. Doherty , F. Walker , J. Weinstock
Biochemical Pharmacology 71 ( 10) 1422 -1434
69
2006